[Comparative study on the tumor accumulation of 99mTc-tetrofosmin and 99mTc-MIBI in rabbits bearing VX-2 cancer]
- PMID: 9404102
[Comparative study on the tumor accumulation of 99mTc-tetrofosmin and 99mTc-MIBI in rabbits bearing VX-2 cancer]
Abstract
Each of myocardial blood flow imaging agents has a potential usefulness as an agent for tumor scintigraphy. The tumor accumulation and washout of 99mTc-tetrofosmin and 99mTc-MIBI were comparatively studied using rabbits bearing VX-2 cancer. From seventeen to twenty days after the implantation of VX-2 cancer into the femoral region of seven rabbits, tumor to soft tissue accumulation ratio (T/S ratio) of each agent was calculated in early images (5 min after injection) and in late images (50 min after injection). Compared with 99mTc-tetrofosmin, the T/S ratio of 99mTc-MIBI was higher and, moreover, the washout was delayed. These results suggest that there is a difference in tumor accumulation property between these two agents.
Similar articles
-
[Study on tumor accumulation property of 99mTc-HM-PAO and 99mTc-MIBI in rabbits bearing VX-2 cancer].Kaku Igaku. 1995 Feb;32(2):199-203. Kaku Igaku. 1995. PMID: 7715106 Japanese.
-
Technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 uptake in rat myocardial cells.J Nucl Med. 1998 Feb;39(2):266-71. J Nucl Med. 1998. PMID: 9476934
-
Comparative 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-furifosmin uptake in human soft tissue sarcoma cell lines.Eur J Nucl Med. 2000 Dec;27(12):1839-43. Eur J Nucl Med. 2000. PMID: 11189948
-
Single-photon agents for tumor imaging: 201Tl, 99mTc-MIBI, and 99mTc-tetrofosmin.Ann Nucl Med. 2004 Apr;18(2):79-95. doi: 10.1007/BF02985098. Ann Nucl Med. 2004. PMID: 15195755 Review.
-
Monitoring therapy in breast cancer.Nucl Med Commun. 2002 Jul;23(7):619-24. doi: 10.1097/00006231-200207000-00005. Nucl Med Commun. 2002. PMID: 12089483 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources